Humoral and cell-mediated immunity to MSP3 peptides in adults immunized with MSP3 in malaria endemic area, Burkina Faso

We performed a single-blind, randomized phase 1 trial of the long synthetic peptide (LSP) of merozoite surface protein-3 (MSP3) in adults living in Burkina Faso. Thirty eligible volunteers were randomized to receive either the MSP3-LSP candidate vaccine or tetanus toxoid vaccine as a control. A dose...

Descripción completa

Detalles Bibliográficos
Autores principales: NEBIE, I, DIARRA, A, OUEDRAOGO, A, TIONO, A B, KONATE, A T, GANSANE, A, SOULAMA, I, COUSENS, S, LEROY, O, SIRIMA, S B
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2009
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2759983/
https://www.ncbi.nlm.nih.gov/pubmed/19646212
http://dx.doi.org/10.1111/j.1365-3024.2009.01130.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2759983/
https://www.ncbi.nlm.nih.gov/pubmed/19646212
http://dx.doi.org/10.1111/j.1365-3024.2009.01130.x

Ejemplares similares